ICDX — Incordex Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -101% | ||
| Return on Equity | n/a | ||
| Operating Margin | -68.1% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | 0 | 0.01 | 0.01 | 0.03 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Incordex Corp. is a development stage company, which is formed to offer handwritten letter service via its Website platform. Its customers include business and private persons. The Company’s customers use its services to send real handwritten letters to prospects and new customers. Its main customers are direct mail marketing companies. Additionally, the Company is engaged in developing and selling Customer Relationship Management (CRM) program designed to assist businesses in sending handwritten letters to their customers. Also, the Company develops Reporting and Analytics Software analytics to help its customers see how effective these handwritten letters are in their marketing campaigns.
Directors
- Last Annual
- June 30th, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- June 12th, 2020
- Public Since
- November 27th, 2023
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 6,450,000
- Address
- 6 Rosemary Way, NUNEATON, CV10 7ST
- Web
- Phone
- +44 7028794409
- Auditors
- Boladale Lawal & CO
Similar to ICDX
1PM Industries
Pink Sheets on Nasdaq
3Dshopping.Com
Pink Sheets on Nasdaq
3 Sixty Risk Solutions
Pink Sheets on Nasdaq
Adecco AG
Pink Sheets on Nasdaq
Adm Endeavors
Pink Sheets on Nasdaq
FAQ
As of Today at 21:16 UTC, shares in Incordex are trading at $1.30. This share price information is delayed by 15 minutes.
Shares in Incordex last closed at $1.30 and the price had moved by over the past 365 days. In terms of relative price strength the Incordex share price has matched the S&P500 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreIncordex does not currently pay a dividend.
Incordex does not currently pay a dividend.
Incordex does not currently pay a dividend.
To buy shares in Incordex you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.30, shares in Incordex had a market capitalisation of .
Here are the trading details for Incordex:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: ICDX
Based on an overall assessment of its quality, value and momentum Incordex is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Incordex. Over the past six months, its share price has matched the S&P500 Index by .
As of the last closing price of $1.30, shares in Incordex were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Incordex PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Incordex's directors